Research
And Grants
Note: When clicking the "Submit Grant Application" button below you will be redirected to SnapGrant.com to complete the application process.
Submit Grant ApplicationThe Cure Starts Now has funded $25,466,182 (USD) in pediatric brain cancer research in partnership with the DIPG / DMG Collaborative. This includes 170 grants at over 100 hospitals in 29 countries.
Note: All Grants Are U.S. Funded Through 2018

Children's Cancer Institute (AU) - $185,706
$185,706.00
October 2017
Developing novel combination therapeutic approaches for DIPG targeting Polo-like Kinase 1

Children's National Medical Center - $200,000
$200,000.00
October 2017
Validation of TAK228 as an effective drug for treating children with DIPG

Ann & Robert H. Lurie Children's Hospital - $100,000
$100,000.00
October 2017
Determine the efficacy of BMP and MEK inhibitors with RT to treat ACVR1 mutant DIPG

Anschutz Medical Campus - $50,000
$50,000.00
September 2017
Toward a Multimodality Cure for DIPG: Investigation of Intratumoral Drug Penetration and Craniospinal Irradiation.

Massachusetts General Hospital - $50,000
$50,000.00
September 2017
Repurposing Mefloquine for Diffuse Intrinsic Pontine Glioma Therapy

CONNECT Consortium - $893,678.37
$893,678.00
September 2017
CONNECT (COllaborative Network for NEurooncology Clinical Trials) Consortium

University of Massachusetts Medical School - $50,000
$50,000.00
May 2017
Advanced RNAi therapeutics for DIPG

Lucile Packard Children's Hospital Stanford - $50,000
$50,000.00
May 2017
Cellular Cybercriminals: DIPG Hacks into the Neural Communication Infrastructure

Hospital for Sick Children - $50,000
$50,000.00
September 2016
MRI Guided Focused Ultrasound: Targeted Drug Delivery in Diffuse Intrinsic Pontine Glioma

Gustave Roussy Cancer Center - $93,071
$93,071.00
September 2016
Ultrasound-induced delivery of Panobinostat in preclinical models

The Hospital for Sick Children - $194,260
$194,260.00
September 2016
Exploring the interactome of H3K27M to find therapeutic targets for DIPG

Cold Spring Harbor Laboratory - $100,000
$100,000.00
September 2016
Allele-specific antisense therapy for DIPG

Children's Cancer Institute - $143,884
$143,884.00
September 2016
Radiosensitisation of Diffuse Intrinsic Pontine Gliomas by modulating the glucose metabolism

Dana-Farber Cancer Institute - $100,000
$100,000.00
December 2015
Characterizing resistance mechanisms to radiation therapy and adjuvant chemotherapy in Diffuse Intrinsic Pontine Glioma

Cincinnati Children's Hospital Medical Center - $100,000
$100,000.00
December 2015
An early Phase 2 Study of LEE011, a CDK4/6 Inhibitor, following radiation therapy in Children with Newly Diagnosed non-biopsied Diffuse Pontine Gliomas (DIPG) and Rb+ biopsied DIPG and High Grade Gliomas (HGG)